Pseudoxanthoma elasticum: cardiac findings in patients and Abcc6-deficient mouse model

Fabrice Prunier1, Gwenola Terrien, Yannick Le Corre

  • 1LUNAM Université, Angers, France. FaPrunier@chu-angers.fr

Plos One
|August 13, 2013
PubMed

Insights

Pseudoxanthoma elasticum (PXE) patients show few cardiac issues, but PXE mice develop hypertrophy later in life. This suggests older PXE individuals may face late-onset heart problems.

Area of Science:

  • Cardiology
  • Genetics
  • Rare Diseases

Background:

  • Pseudoxanthoma elasticum (PXE) is a rare genetic disorder affecting connective tissue due to ABCC6 gene mutations.
  • PXE is characterized by mineralization and fragmentation of elastic fibers, with cardiac complications primarily documented in case reports.

Purpose of the Study:

  • To prospectively assess cardiac involvement in a cohort of PXE patients.
  • To investigate cardiac function and structure in a PXE mouse model (Abcc6(-/-)) compared to wild-type controls.

Main Methods:

  • 67 PXE patients underwent comprehensive cardiac evaluations including ECG, echocardiography, CMR, treadmill tests, and SPECT.
  • PXE mouse models (Abcc6(-/-)) and wild-type controls were analyzed for cardiac function and histology at various ages.

Main Results:

  • PXE patients showed no frequent cardiac complications; treadmill tests were negative, and SPECT revealed mild perfusion abnormalities in two patients.
  • While LV dimensions and function were normal, 10.4% of PXE patients had LV hypertrophy of unknown etiology. Valvulopathies were frequent but insignificant.
  • Abcc6(-/-) mice developed cardiac hypertrophy by 24 months without contractile dysfunction, unlike younger mice or WT controls.

Conclusions:

  • PXE is not frequently associated with cardiac complications in humans, contrary to some case reports.
  • Cardiac hypertrophy observed in aged Abcc6(-/-) mice indicates a potential for late-onset cardiopathy in elderly PXE patients.
Abstract

Related Concept Videos